HIV/AIDS Data Hub for the Asia-Pacific Region
 
You are here: Reference Library
Reference Library
Core New_Funding_Model_Overview_2013-1

The new model provides implementers with more flexible timing, better alignment with national strategies and greater predictability on the level of funding available. There is more active engagement with implementers and partners throughout grant application and implementation to ensure greater global impact. 

Download this publication

Seeking redress_HIVrelated_violations_of_human_rights_Philippines-1

Reddress is an act or process meant to correct a situation involving the violation of a right. It could be to address a past injury or violation, or to prevent future harm. Redress is usually obtained through the courts, although there are some out-of-court mechanisms that could also result in redress.

 

Download this publication
HSS 2012_Myanmar-1

The annual HIV Sentinel Sero‐surveillance survey, the systematic and regular collection of information on the occurrence, distribution and trends of HIV infection and factors associated with the infection, has been carried out since 1992. The survey has been conducted among 8 targeted sentinel groups: Pregnant Women attending the antenatal clinics (ANC), New Military Recruits, Blood Donors, newly diagnosed TB patients, People who inject drugs (PWID), Men who have Sex with Men (MSM), Female Sex Workers (FSW) and Male patients attending sexually transmitted infection (STI) clinic.

Download this publication
Global AIDS_Response_Progress_2013-1

The purpose of this document is to provide guidance to national AIDS programmes and partners actively involved in the country response to AIDS on use of core indicators to measure and report on the national response.

Download this document
Reducing HIV_and_Key_Population_on_Stigma_and_Discrimination_Thailand_Lao_Myanmar_2012-1

Tackling S&D for improved HIV prevention and treatment is particularly critical in GMR countries of the Lao People’s Democratic Republic (Lao PDR), Myanmar and Thailand, given that the epidemic is concentrated and growing amongst groups who face not only HIV-related S&D, but also the underlying and HIV-associated stigmas of sex work, drug use, gender identity, and same-sex relationships. 

 

Download this publication
Global Investments_in_HIV_Treatment_Research_and_Development_2010-2011-1

Development of new, simpler, more effective and affordable compounds will continue to be essential for attaining the goal of putting at least 15 million people on ART by 2015, as set forth in the 2011 Political Declaration on HIV and AIDS.2 To this end, pharmaceutical industry leaders moved seven compounds into phase III studies in 2010 and 2011, and seven compounds into phase II. The focus of development is on compounds that can be taken as a single pill once daily, thus simplifying treatment, improving adherence, and reducing the risk of stockout-induced resistance to individual drugs.

Download this publication
Summary Report_Drug_Use_in_Pakistan_2013-1

The technical summary of the Drug Use in Pakistan 2013 Report launched during the Commission on Narcotic Drugs reveals how a substantial proportion of Pakistan's population aged 15 to 64 suffer from the devastating consequences of substance abuse. The Report estimates that 5.8 per cent - or 6.4 million adults in Pakistan - used drugs in the last 12 months. Although 4.1 million individuals are thought to be drug dependent, treatment and specialist interventions are in short supply, available to less than 30,000 drug users a year. Moreover, not all structured treatment is free of charge. In a country where almost a quarter of the population is estimated to be living on less than US$ 1.25 a day, the barriers preventing access to structured treatment are exceptionally high.

Download this publication
Guidelines Finish_Myanmar_HIV_Clinical_2011-1

These guidelines have been written to serve all medical personal treating patients with HIV in Myanmar. It is meant not only for the National AIDS-STD program me but also for local in international NGOs, hospital doctors and general practitioners in the public and private sectors.

Download this document
cover-coming-soon

People who inject drugs should benefit from the large increases in the global resources available for HIV. However, it is difficult to measure how much of global HIV spending actually goes into harm reduction. Although harm reduction is relatively invisible in national and international budgets, it is possible to calculate a plausible estimate of HIVrelated harm reduction expenditure in low and middle income countries between 2007 and 2009. These results demonstrate the degree to which the international community is failing to address the issue of HIV among injecting drug using populations.

Download this publication

Page 2 of 434

Children categories